Single-cell and spatial profiling reveal an IL-10–associated iCAF–M2 macrophage communication axis in high-grade serous ovarian cancer ascites - Scorecard - MDSpire
Advertisement
Single-cell and spatial profiling reveal an IL-10–associated iCAF–M2 macrophage communication axis in high-grade serous ovarian cancer ascites
Clinical Scorecard: Characterization of IL-10-Driven Communication Between iCAF and M2 Macrophages in Ascites of High-Grade Serous Ovarian Cancer Through Single-Cell and Spatial Profiling
At a Glance
Category
Detail
Condition
High-Grade Serous Ovarian Cancer (HGSOC)
Key Mechanisms
IL-10–IL-10RA signalling linking inflammatory CAFs with M2-like macrophages
Target Population
Patients with advanced-stage HGSOC
Care Setting
Oncology research and clinical trials
Key Highlights
IL-10 blockade reverses M2 polarization and suppresses tumor progression.
Single-cell RNA sequencing reveals macrophages and CAFs as dominant populations in HGSOC ascites.
IL-10 is significantly elevated in ovarian cancer ascitic fluid compared to serum.
M2 macrophages are associated with exhausted immune states in the tumor microenvironment.
Multiplex immunofluorescence confirms spatial interactions between IL-10+ iCAFs and IL-10RA+ M2 macrophages.
Guideline-Based Recommendations
Diagnosis
Utilize single-cell RNA sequencing to characterize immune cell populations in ascites.
Management
Consider IL-10 blockade as a therapeutic strategy in HGSOC.
Monitoring & Follow-up
Assess IL-10 levels in ascitic fluid as a prognostic marker.
Risks
Monitor for potential immune-related adverse effects associated with IL-10 blockade.
Patient & Prescribing Data
Patients with advanced high-grade serous ovarian cancer and ascites.
IL-10 blockade with MK-1966 significantly suppresses tumor growth and M2 macrophage markers.
Clinical Best Practices
Incorporate single-cell analysis to understand tumor microenvironment dynamics.
Evaluate the role of cytokines in shaping immune responses in ovarian cancer.
